Author:
Dickler Maura N.,Cobleigh Melody A.,Miller Kathy D.,Klein Pamela M.,Winer Eric P.
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. Arteaga CL (2002) Epidermal growth factor receptor dependence in human tumors: more than just expression? Oncologist 7(Suppl 4):31–39. doi: 10.1634/theoncologist.7-suppl_4-31
2. Shepherd FA, Rodrigues Pereira J, Ciuleanu T et al (2005) Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 353:123–132. doi: 10.1056/NEJMoa050753
3. Moore MJ, Goldstein D, Hamm J et al (2007) Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 25:1960–1966. doi: 10.1200/JCO.2006.07.9525
4. Erbitux® [package insert 11/07]. ImClone Systems Incorporated, New York, NY; Bristol-Myers Squibb Company, Princeton, NJ
5. Vectibix™ [package insert 10/07]. Amgen Inc., Thousand Oaks, CA
Cited by
113 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献